Image

Dysfunctional Breathing in Post COVID-19 Condition.

Dysfunctional Breathing in Post COVID-19 Condition.

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this observational study with a cross-sectional design is to investigate what signs, symptoms and assessment which can describe and explain dysfunctional breathing in patients with post COVID-19 condition. The main question aims to answer which measurements can identify and asses dysfunctional breathing in patients with post COVID-19 condition?

Participants for this study will be recruited from the ReCov cohort will be evaluated with diffrent measurments and questionnaires.

Description

The overall aim with the proposed research project is to describe and investigate the underlying mechanisms of dysfunctional breathing and the experience of living with dysfunctional breathing in patients with post-COVID-19 conditions. In addition, validate and evaluate which methods measure dysfunctional breathing regarding content validity, conceptual validity, test-retest reliability, and sensitivity to change for patients with post-COVID-19 conditions. Furthermore, to develop and evaluate an individually adapted intervention with the aim of normalizing the breathing pattern. In the next step, to evaluate the effects of an individually adapted intervention on physical and psychological function and health-related quality of life (HRQoL) in patients with post-COVID-19 conditions, as well as to describe the patients' experiences of rehabilitation.

Methods and planned studies This project is a part of a larger multi-disciplinary and multi-professional study, ReCOV, that takes a holistic perspective on the consequences of the disease. ReCOV is a three-armed project including patients, next of kin and staff (23). Patients have been followed up at the out-patient clinic for patients with PCC at Karolinska University Hospital (K).

The longitudinal observational study is about physical and psychological recovery, objectively measured physical activity and also an interview study of the patients' overall experiences of rehabilitation after COVID-19 both in the acute and long-term perspective. In total approximately 950 patients have accepted to be apart of ReCOV and to this proposed project patients will be recruited from this cohort but also from primary care. This research project will be performed in collaboration with Karolinska Institutet, Karolinska university Hospital (K), Sahlgrenska University Hospital (SH). University of Gothenburg and primary care in Region Stockholm.

Study 1: Dysfunctional breathing in patients with post COVID-19 condition?

Aim: To investigate what signs, symptoms and assessment which can describe and explain dysfunctional breathing in patients with post COVID-19 condition.

Design: Cross-sectional design

Participants: Patients (approximately n=200) for this study will be recruited from the ReCov cohort. All patients will be > 18 years old. Patients that state that they have persistent respiratory problems and abnormal clinical respiratory findings will be included. Patients will also be recruited from primary care if they have suspected dysfunctional breathing pattern (unable to breathe with a normal breathing pattern in standing). Exclusion Criteria: Not able to perform the measurements because of cognitive or physical impairments, ongoing intervention of breathing exercises.

Procedure and outcomes: All included patients will be evaluated for physical and psychological function, symptoms and HrQoL. The following measurements and questionnaires will be used:

Dependent variables (primary outcome):

Health-related Quality of Life (EQ-5D-5L), EQ VAS Breathing pattern by Respiratory Movement Measuring Instrument (RMMI)

Independent, confounding and possible moderating variables:

Inspiratory and expiratory muscle strength (MIP and MEP) (Micro-RPM) Chest mobility by thoracic expansion Six-minute walk to measure endurance (in meters) Spirometry Diaphragmatic ultrasound End tidal CO2 measured during exercise

Physical Activity level (Frändin/ Grimby) Nijmegen questionnaire (dysfunctional breathing) COPD Assessment Test (CAT), questionnaire of symptoms related to breathing and now commonly used for this group of patients Dyspnea (mMRC, Modified Medical Research Council, Dyspnea Scale and BORG CR10) Patient Health Questionnaire (PHQ-9) Generalized Anxiety Disorder 7-item scale (GAD-7) Breathing Pattern Assessment Tool (BPAT)

Eligibility

Inclusion Criteria:

  • Patients that state that they have persistent respiratory problems, have 2 or higher on mMRC scale or 23 and over on the Nijmegen scale will be included.

Exclusion Criteria:

  • Not able to perform the measurements because of cognitive or physical impairments, ongoing intervention of breathing exercises.

Study details
    Post COVID-19 Condition (PCC)
    Dysfunctional Breathing
    Breathing Pattern Disorder
    Post-Acute COVID-19 Syndrome

NCT06776263

Karolinska Institutet

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.